Native Cardio Board of Directors
Joseph Pergolizzi, MD, Executive Chairman – Dr. Joseph V. Pergolizzi, Jr. is an internationally recognized thought leader in anesthesiology, internal medicine, perioperative care, pain medicine, critical and palliative care, pharmacology, drug development and regulatory affairs. As a drug and device regulatory subject matter expert, Dr. Pergolizzi is a top consultant for numerous blockbuster-branded medications. He is an experienced C-suite executive who brings an extensive professional network and background in global healthcare to Native Cardio.
He is the co-founder of NEMA Research, Inc., a specialty CRO, a former invited subcommittee member of the FDA Safe Use Initiative, an SGE VAH Grant Reviewer, a section Chairman of PAINWEEK, and Consultant to Global Pain Initiative’s Board of Directors. Dr. Pergolizzi is the former director of business development and financial affairs for the Johns Hopkins University School of Medicine Clinical Trials Unit and a former part-time adjunct faculty member in the Department of Medicine at Johns Hopkins University School of Medicine.
Dr. Pergolizzi has published over 100 peer-reviewed medical articles and is frequently invited to share his presentations at scientific conferences around the world.
Young D. Kim, MD, Board Member and Co-founder – Dr. Kim is former Chairman and Professor, Department of Anesthesia, Georgetown University Medical Center 2004-2012. Dr. Kim is a former NIH researcher with over 40-years of cardiovascular anesthesia clinical and research experience. Dr. Kim has been awarded multiple research grants for his work and has exhibited his findings at numerous scientific conferences. Dr. Kim is the author of over 150 peer-reviewed articles, abstracts, and platform presentations in his areas of interest and expertise. He is an internationally recognized expert and is in demand as a lecturer. He holds U.S. patents for his innovations.
Myles P. Dempsey joined the Native Cardio Board in February 2019. He is the Founder and retired CEO of Tech Air, a leading industrial gas distributor in the Northeast. Myles sold Tech Air in 2011 to Private Equity firm CI Capital Partners after more than 30 years as its leader. Prior to founding Tech Air Myles was responsible for acquisitions within the Linde Division of Union Carbide. For the past decade, Myles has been an active supporter of numerous medical research pilot projects at Sloan Kettering and the Albert Einstein Cancer Institute, with a particular focus on breast and colon cancer. This has resulted in significant NIH grants being awarded to both institutions to continue this critical research.